back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-05-21 16:54 Tx date 2024-05-16 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$356,000
+50,000 vol $7.12 each |
410,246 | |
| Filed 2024-04-23 18:05 Tx date 2024-04-23 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-207,029.468
-22,223 vol $9.32 each |
0 | |
| Filed 2024-04-23 18:04 Tx date 2024-04-23 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$51,335
+22,223 vol $2.31 each |
22,223 | |
| Filed 2024-04-23 18:04 Tx date 2024-04-22 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-207,460.1476
-22,222 vol $9.34 each |
0 | |
| Filed 2024-04-23 17:56 Tx date 2024-04-22 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$51,332
+22,222 vol $2.31 each |
22,222 | |
| Filed 2024-04-23 17:56 Tx date 2024-04-19 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-213,775.64
-22,222 vol $9.62 each |
0 | |
| Filed 2024-04-23 17:55 Tx date 2024-04-19 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$51,332
+22,222 vol $2.31 each |
22,222 | |
| Filed 2024-04-23 17:54 Tx date 2024-04-18 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-220,220.02
-22,222 vol $9.91 each |
0 | |
| Filed 2024-04-23 17:53 Tx date 2024-04-18 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$51,332
+22,222 vol $2.31 each |
22,222 | |
| Filed 2024-04-23 17:51 Tx date 2024-04-23 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-51,335.13
-22,223 vol $2.31 each |
360,246 | |
| Filed 2024-04-23 17:50 Tx date 2024-04-22 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-51,332.82
-22,222 vol $2.31 each |
382,469 | |
| Filed 2024-04-23 17:50 Tx date 2024-04-19 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-51,332.82
-22,222 vol $2.31 each |
404,691 | |
| Filed 2024-04-23 17:49 Tx date 2024-04-18 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-51,332.82
-22,222 vol $2.31 each |
426,913 | |
| Filed 2024-04-16 18:20 Tx date 2024-04-16 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-228,388.8272
-22,222 vol $10.28 each |
0 | |
| Filed 2024-04-16 18:20 Tx date 2024-04-15 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-228,793.2676
-22,222 vol $10.30 each |
0 | |
| Filed 2024-04-16 18:18 Tx date 2024-04-16 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$51,332
+22,222 vol $2.31 each |
22,222 | |
| Filed 2024-04-16 18:17 Tx date 2024-04-15 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$51,332
+22,222 vol $2.31 each |
22,222 | |
| Filed 2024-04-16 18:16 Tx date 2014-04-28 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-04-16 18:15 Tx date 2024-04-16 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-51,332.82
-22,222 vol $2.31 each |
449,135 | |
| Filed 2024-04-16 18:14 Tx date 2024-04-15 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-51,332.82
-22,222 vol $2.31 each |
471,357 | |
| Filed 2023-08-07 09:11 Tx date 2023-08-07 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,605,999
+200,000 vol $8.03 each |
493,579 | |
| Filed 2023-06-13 10:20 Tx date 2023-06-12 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$175,600
+20,000 vol $8.78 each |
293,579 | |
| Filed 2022-06-16 09:40 Tx date 2022-06-14 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$111,800
+20,000 vol $5.59 each |
273,579 | |
| Filed 2021-06-30 16:40 Tx date 2021-06-29 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$150,400
+20,000 vol $7.52 each |
253,579 | |
| Filed 2021-02-02 22:21 Tx date 2021-01-28 |
$ACH
Arch Biopartners Inc. |
Haigh, Adrian J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$22,500
+50,000 vol $0.45 each |
130,000 | |
| Filed 2021-02-02 22:18 Tx date 2021-01-28 |
$ACH
Arch Biopartners Inc. |
Haigh, Adrian J.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-50,000 vol |
350,000 | |
| Filed 2020-08-14 08:39 Tx date 2020-08-13 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$123,400
+20,000 vol $6.17 each |
233,579 | |
| Filed 2020-06-14 17:20 Tx date 2020-06-11 |
$ACH
Arch Biopartners Inc. |
Haigh, Adrian J.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$148,000
+100,000 vol $1.48 each |
400,000 | |
| Filed 2019-10-11 15:43 Tx date 2019-10-10 |
$ACH
Arch Biopartners Inc. |
Haigh, Adrian J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$15,000
+50,000 vol $0.30 each |
80,000 | |
| Filed 2019-10-11 15:42 Tx date 2019-10-10 |
$ACH
Arch Biopartners Inc. |
Haigh, Adrian J.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-15,000
-50,000 vol $0.30 each |
300,000 | |
| Filed 2019-06-19 12:50 Tx date 2019-06-18 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$85,200
+20,000 vol $4.26 each |
213,579 | |
| Filed 2018-06-10 Tx date 2018-06-08 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$218,600
+20,000 vol $10.93 each |
193,579 | |
| Filed 2018-05-09 Tx date 2018-05-08 |
$ACH
Arch Biopartners Inc. |
Haigh, Adrian J.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$78,000
+100,000 vol $0.78 each |
350,000 | |
| Filed 2017-06-28 Tx date 2017-06-27 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$102,000
+20,000 vol $5.10 each |
173,579 | |
| Filed 2017-04-21 Tx date 2017-04-18 |
$ACH
Arch Biopartners Inc. |
Haigh, Adrian J.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,000
+100,000 vol $0.50 each |
250,000 | |
| Filed 2016-08-31 Tx date 2016-08-29 |
$ACH
Arch Biopartners Inc. |
Haigh, Adrian J.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
150,000 | |
| Filed 2016-06-10 Tx date 2016-06-09 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,000
+10,246 vol $2.44 each |
153,579 | |
| Filed 2016-02-01 Tx date 2016-01-28 |
$ACH
Arch Biopartners Inc. |
Haigh, Adrian J.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,500
+50,000 vol $0.45 each |
100,000 | |
| Filed 2015-05-13 Tx date 2014-12-31 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$26,900
+10,000 vol $2.69 each |
143,333 | |
| Filed 2015-05-13 Tx date 2014-09-03 |
$FRX
Fennec Pharmaceuticals Inc. |
Haigh, Adrian J.
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-266,667 vol |
133,333 |